Open AccessEfficacy of combined antiviral therapy with pegylated interferon α-2a and ribavirin for chronic hepatitis C infection in intravenous drug users
Author(s) -
Maja Ružić,
Milotka Fabri,
Biljana Klasnja,
Marta Pobor,
Daniela Svarc,
Aleksandra Jovelić,
Izabela Fabri
Publication year - 2010
Publication title -
srpski arhiv za celokupno lekarstvo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 17
eISSN - 2406-0895
pISSN - 0370-8179
DOI - 10.2298/sarh1002043r
Subject(s) - medicine , ribavirin , pegylated interferon , drug , chronic hepatitis , hepatitis c , antiviral therapy , interferon , virology , intravenous drug , pharmacology , intensive care medicine , virus , viral disease
Hepatitis C Virus infection represents not just a medical, but also a socio-economic problem. It is estimated that among 170 million infected, 60% belongs to the category of intravenous drug users (IDUs).